Full Text
Full text is available in PDF
Background:
There is limited data on the natural history of autoimmune hepatitis (AIH) and on the long-term follow-up of AIH patients who have been referred for regular medical attention.
Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Clinical Features and Long Term Outcome of 102 Treated Autoimmune Hepatitis Patients
Author(s):
Zinab Malekzadeh1, Zinab Malekzadeh2, Sepideh Haghazali1, Sepideh Haghazali1, Sadaf G Sepanlou1, Sadaf G. Sepanlou1, Homayoon Vahedi1, Homayoon Vahedi2, Shahin Merat1, Shahin Merat2, Masoud Sotoudeh1, Masoud Sotoudeh3, Siavosh Nasseri-Moghaddam1, Siavosh Nasseri-Moghaddam2, 
Reza Malekzadeh2,*, Reza Malekzadeh2,*1Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
2Sasan Alborz Biomedical Research Institute, Tehran, IR Iran
3Department of Pathology, Shariati Hospital, Tehran University of Medical sciences, Tehran, IR Iran
Corresponding Authors:
Published online:Jan 31, 2012
Article type:Research Article
Received:Oct 18, 2011
Accepted:Dec 25, 2011
How to Cite:Zinab Malekzadeh, Zinab Malekzadeh, Sepideh Haghazali, Sepideh Haghazali, Sadaf G Sepanlou, et al. Clinical Features and Long Term Outcome of 102 Treated Autoimmune Hepatitis Patients.Hepat Mon.2012;12(2):92-99.https://doi.org/10.5812/hepatmon.808.
Abstract
Objectives:
We evaluated the clinical presentation and natural history of AIH in a large cohort of type I AIH patients from Iran.
Patients and Methods:
Between 1997 and 2008, 102 patients were enrolled in the study. Patients were diagnosed using the International Autoimmune Hepatitis Group criteria and were followed up for an average of 60 months. Clinical and biochemical data were gathered from all the patients at both the beginning and the end of the follow-up period. Liver biopsy was performed in all patients before treatment, and the biopsies were performed in 28 patients after treatment.
Results:
Biochemical remission was achieved by 80 (79.4%) patients. Of these, 53 (66.5%) showed near-normal liver histology or liver function test results and sonogram. The remaining 27 (33.5%) patients also achieved clinical and biochemical remission, but developed compensated cirrhosis. After a period of remission, 24 patients (32.5%) relapsed. Among the 22 (21.6%) patients who showed ultimate treatment failure, 6 underwent orthotopic liver transplantation and 3 died of liver failure while awaiting a transplant. Sixteen (72.7%) of the 22 patients who did not respond to therapy were non-compliant with medications and had irregular follow-up. The overall 10-year survival rate in the cohort was 96%.
Conclusions:
Long-term survival in AIH patients is very good. Prompt diagnosis and appropriate first-line and salvage therapy that includes close follow-up will make liver transplantation a rare necessity in the treatment of this disease.
Copyright
© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
comments
Leave a comment here
Crossmark
Checking
Comments
Number of Comments:0Cited by
Purchasing Reprints
- Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations
Author(s):
- Zinab Malekzadeh:[PubMed][Scholar]
- Zinab Malekzadeh:[PubMed][Scholar]
- Sepideh Haghazali:[PubMed][Scholar]
- Sepideh Haghazali:[PubMed][Scholar]
- Sadaf Sepanlou:[PubMed][Scholar]
- Sadaf G. Sepanlou:[PubMed][Scholar]
- Homayoon Vahedi:[PubMed][Scholar]
- Homayoon Vahedi:[PubMed][Scholar]
- Shahin Merat:[PubMed][Scholar]
- Shahin Merat:[PubMed][Scholar]
- Masoud Sotoudeh:[PubMed][Scholar]
- Masoud Sotoudeh:[PubMed][Scholar]
- Siavosh Nasseri-Moghaddam:[PubMed][Scholar]
- Siavosh Nasseri-Moghaddam:[PubMed][Scholar]
- Reza Malekzadeh:[PubMed][Scholar]
- Reza Malekzadeh:[PubMed][Scholar]
Related Articles